bioRxivMolecular BiologyPreprint
Signalling Network of Breast Cancer Cells in Response to Progesterone
Roni H. G. WrightiD, Viviana VastoloiD, Javier QuileziD, José Carbonell‐CaballeroiD, Miguel BeatoiD
Abstract
Breast cancer cells enter into the cell cycle following progestin exposure by the activation of signalling cascades involving a plethora of enzymes, transcription factors and co-factors that transmit the external signal from the cell membrane to chromatin, ultimately leading to a change of the gene expression program. Although many of the events within the signalling network have been described in isolation, how they globally team up to generate the final cell response is unclear. In this study we use antibody microarrays and phosphoproteomics to provide a dynamic global signalling map that reveals new key regulated proteins and links between previously known and novel pathways. Detailed analysis of the data revealed intriguing changes in protein complexes involved in nuclear structure, EMT, cell adhesion, as well as transcription factors previously not associated with breast cancer proliferation. As different post-translational modifications can mediate complex crosstalk mechanisms and massive PARylation is also rapidly induced by progestins, we provide details of important chromatin regulatory complexes containing both phosphorylated and PARylated proteins. This study contributes an important resource for the scientific community, as it identifies novel players and connections meaningful for breast cancer cell biology and potentially relevant for cancer management. (197 w)
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A progesterone derivative linked to a stable phospholipid activates breast cancer cell response without leaving the cell membrane
Jofre Font-Mateu, Pol Sanllehí, … Miguel Beato·Cellular and Molecular Life SciencesPeer-reviewed·Feb 22, 2024
- Breast cancer cells can recognize and respond to different levels of progestins to achieve different phenotypic outputs
E. L. Dolan, R. Safi, … D. P. McDonnell·bioRxiv·Oct 13, 2023
- CCM signaling complex (CSC) coupling both classic and non-classic progesterone receptor signaling
Johnathan Abou‐Fadel, Xiaoting Jiang, … Jun Zhang·bioRxiv·May 24, 2020
- Characterization of p38a signaling networks in cancer cells using quantitative proteomics and phosphoproteomics
Y. Dan, N. Radic, … A. R. Nebreda·bioRxiv·Sep 9, 2022
- Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood
B. Orcutt-Jahns, J. R. Lima Junior, … A. S. Meyer·bioRxiv·Oct 31, 2023
- Omics analysis reveals striking effects of progesterone receptor on mitochondria and mitochondria-mediated apoptosis independent of caspases in Breast Cancer cells
Qian Yee Woo, Pheck Khee Lau, … Valerie C. L. Lin·bioRxiv·Mar 6, 2025